How Integrated Technology Benefits Patients and Investigators in Diabetes Clinical Trials

For access to the full issue, click here.

About the Author

Jill Platko

Dr. Jill V. Platko is a Senior Scientific Advisor at CRF Health. She has over 16 years of experience in biology-based scientific research and has led projects for renowned institutions such as: Cornell University, Genome Therapeutics Corporation, Whitehead Institute Center for Genome Research, & Massachusetts General Hospital. Dr. Platko completed her PhD in Genetics and Development at Cornell University, and she received a BS in Biology from the State University of New York at Albany.

More Content by Jill Platko
Previous
CRF Health’s TrialMax eCOA Solution Selected for Landmark Pain Outcomes Study by Global Japanese Pharmaceutical Company
CRF Health’s TrialMax eCOA Solution Selected for Landmark Pain Outcomes Study by Global Japanese Pharmaceutical Company

CRF Health announces that its TrialMax Touch® and TrialMax Slate® solutions have been selected by a Global ...

Next
CRF Health Scoops 2018 TrialConsent® Hat Trick as CARE Award Finalist
CRF Health Scoops 2018 TrialConsent® Hat Trick as CARE Award Finalist

CRF Health's TrialConsent (eConsent Solution) Shortlisted as Best Patient-Focused Technological Development...